The underlying mechanism from a developmental point of view is unexplored, but data from peripheral blood suggest that XIAP counteracts a proneness to increased apoptosis in iNKT cells mediated by PLZF, which may explain the abrogated iNKT cell development in XLP patients with a XIAP deficiency (77). This evidence concerns the gene XIAP and X-linked lymphoproliferative disease.